Tag: Testing

Posted on

Government Mandated Validation and Testing Bolsters Growth

Government Mandated Validation and Testing Bolsters Growth
Company Logo

Company Logo

Dublin, March 10, 2023 (GLOBE NEWSWIRE) — The “Medical Device Analytical Testing Outsourcing Market by Service, End-user: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.

The medical device analytical testing outsourcing market valued for $4,744.84 million in 2021 and is estimated to reach $7,956.99 million by 2031, exhibiting a CAGR of 5.3{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} from 2022 to 2031.

Key factors driving the growth of the medical device analytical testing outsourcing market include growing need for medical testing and validation for medical devices and rise in adoption of analytical testing services such as physical testing, sterility testing, and others. In addition, rise in adoption of the medical devices such as cardiovascular devices, orthopedic devices, dental implants have led to increase the demand for analytical testing services for medical devices and further supports the growth of market.

Furthermore, rise in standards and regulations relating to services for medical device validation and verification stimulate the growth of the market. In addition, various initiatives by public organizations promoting the testing of medical devices drive the market growth.

Furthermore, Food Drug Administration (FDA) has regulated the guidelines, for ensuring the products quality, safety, and accuracy before its use. Hence, validation and medical testing is necessary for medical equipment which further contributes toward market growth.

Moreover, presence of well-established healthcare systems and rise in healthcare expenditure boost the market growth. Thus, increase in the prevalence of cardiovascular disease among population, presence of well-established healthcare systems, and rise in R&D activities for cardiovascular disease led to increases the demand for outsourcing of cardiovascular devices which contributes towards market growth.

The market also offers growth opportunities to the key players in the market. Rise in affordability of healthcare infrastructure and surge in medical expenditure in developing countries such as China, Japan, India and rise in healthcare spending this has led to surge in demand for medical devices analytical testing services, thereby provides the lucrative opportunity to the market growth. In addition, strong presence of pharmaceutical manufacturers in the developed countries are expected to create a positive impact on the market growth.

Furthermore, rise in health care expenditure significantly impacts growth of various pharmaceutical sectors in the healthcare industry. For instance, according to the Medicare and Medicaid Services, the National Health Expenditure (NHE) reached $3.8 trillion in 2019. The NHE increased by 4.6{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} in 2019 and accounted for 17.7{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} of the U.S. GDP.

Thus, increase in healthcare spending, surge in demand for medical devices analytical testing, owing to increase in prevalence of chronic diseases are expected to provide remunerative opportunities for expansion of the global medical device analytical testing outsourcing market during the forecast period.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical device analytical testing outsourcing market analysis from 2021 to 2031 to identify the prevailing medical device analytical testing outsourcing market opportunities.

  • The market research is offered along with information related to key drivers, restraints, and opportunities.

  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

  • In-depth analysis of the medical device analytical testing outsourcing market segmentation assists to determine the prevailing market opportunities.

  • Major countries in each region are mapped according to their revenue contribution to the global market.

  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

  • The report includes the analysis of the regional as well as global medical device analytical testing outsourcing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments
By Service

  • Physical Testing

  • Bioburden Testing

  • Sterility Testing

  • Others

By End User

By Region

  • North America

  • U.S.

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • Asia-Pacific

  • Japan

  • China

  • Australia

  • India

  • South Korea

  • Rest of Asia-Pacific

  • LAMEA

  • Brazil

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

Key Market Players

  • SGS SA

  • Medistri SA

  • Element Materials Technology

  • Pace Analytical

  • North American Science Associates, LLC

  • The Smithers Group Inc.

  • Eurofins Scientific

  • Intetek Group plc

  • WuXi AppTec

  • Charles River Laboratories International, Inc.

Key Market Insights

  • By service, the others segment was the highest revenue contributor to the market in 2021 and is estimated to reach $3,812.71 million by 2031, with a CAGR of 4.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f}. However, the sterility testing segment is estimated to be the fastest-growing segment with a CAGR of 7.5{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} during the forecast period.

  • By end user, the medical device manufacturer segment dominated the global market in 2021 and is expected to be the fastest-growing segment with a highest CAGR of 5.7{08cd930984ace14b54ef017cfb82c397b10f0f7d5e03e6413ad93bb8e636217f} during the forecast period.

  • Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period

Key Topics Covered:

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICE

CHAPTER 5: MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER

CHAPTER 6: MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

For more information about this report visit https://www.researchandmarkets.com/r/me588b

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Posted on

Medical Device Analytical Testing Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

Government Mandated Validation and Testing Bolsters Growth
Company Logo

Enterprise Emblem

Dublin, Jan. 26, 2023 (Globe NEWSWIRE) — The “Clinical Gadget Analytical Testing Providers Market place Dimension, Current market Share, Software Analysis, Regional Outlook, Development Traits, Key Players, Competitive Methods and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s featuring.

The goal of this research analyze is to give investors, developers, organization executives, and marketplace individuals with in-depth investigation to allow for them to choose strategic initiatives and conclusions associated to the potential customers in the global medical unit analytical screening companies marketplace. This report provides and analyzes the significant traits widespread in the global health care machine analytical tests expert services market and the current market measurement and forecast.

Clinical products are issue to stringent rules and handle specs. Improvement, introduction, and use of normal complying healthcare products be certain efficacy and safety of these kinds of products. A number of regulatory authorities and companies often collaborate to established standards for health care gadgets. These institution of criteria involves developing overall performance qualities, tests techniques, production practices, solution characters and benchmarks, use protocols, ingredient technical specs, labeling, and other such criteria.

This report categorizes the world wide health care gadget analytical tests companies market in phrases of services variety and geographical distribution. Based on provider sort, the world-wide health care gadget analytical screening services industry is classified into content characterization, extractable & leachable testing, bodily tests, sterility testing, bioburden testing, and other people. Current market measurement and forecast for each individual described phase for the interval 2020-2030 is introduced in the report along with respective CAGRs for the forecast duration 2022-2030.

The current market dimension and forecast of just about every regarded geographical market are presented for the time period 2020-2030 together with CAGRs for the forecast period of time 2022-2030 in this research and are further more cross-sectional introduced in conditions of service sort, and constituent region/country level marketplaces.

Among the the considered provider forms, product characterization retains the most significant revenue share in the all round health care machine analytical screening companies market. Through product characterization expert services, the service suppliers guidance medical gadget companies in setting up biocompatibility by identification and quantification of substances in products. Product characterization is carried out to determine content toxicity and generally follows ISO 10993-18 techniques.

The initial machines producers in North America and Europe have an extra worry of that contains over-all business expenditure while concurrently concentrating on main competency of the development of novel healthcare devices. This has led the professional medical unit companies in these regions to progressively outsource their non-core procedures to third-occasion assistance vendors. Furthermore, as the healthcare infrastructure in Asia Pacific is correspondingly developing to the ever-growing affected individual pool, the Asia Pacific industry is presenting valuable current market penetration opportunities to the multinational giants.

Current market Segmentation
Provider Style

Essential queries answered in this report

  • What are the essential micro and macro environmental variables that are impacting the expansion of Health-related System Analytical Testing Expert services market place?

  • What are the important expense pockets with regard to products segments and geographies now and all through the forecast interval?

  • Believed forecast and market place projections up to 2030.

  • Which section accounts for the quickest CAGR throughout the forecast interval?

  • Which current market section holds a larger sector share and why?

  • Are low and middle-earnings economies investing in the Clinical Unit Analytical Screening Products and services sector?

  • Which is the greatest regional market for Medical Product Analytical Tests Expert services marketplace?

  • What are the market place tendencies and dynamics in rising markets these types of as Asia Pacific, Latin America, and Center East & Africa?

  • Which are the essential trends driving Professional medical Product Analytical Testing Services current market progress?

  • Who are the important competitors and what are their essential strategies to enhance their current market existence in the Medical Machine Analytical Tests Providers sector worldwide?

Critical Subjects Included:

1. Preface

2. Government Summary

3. Professional medical Device Analytical Testing Expert services Industry: Aggressive Investigation

4. Health care Unit Analytical Testing Solutions Market place: Macro Assessment & Marketplace Dynamics

5. Health care Machine Analytical Testing Services Current market: By Provider Kind, 2020-2030, USD (Million)

6. North America Medical Product Analytical Testing Expert services Current market, 2020-2030, USD (Million)

7. United kingdom and European Union Health care Unit Analytical Screening Solutions Sector, 2020-2030, USD (Million)

8. Asia Pacific Healthcare Unit Analytical Screening Companies Market, 2020-2030, USD (Million)

9. Latin The usa Medical Gadget Analytical Tests Services Market, 2020-2030, USD (Million)

10. Center East and Africa Healthcare Product Analytical Testing Companies Marketplace, 2020-2030, USD (Million)

11. Firm Profile

Providers Talked about

  • Avomeen Analytical Solutions

  • Charles River Laboratories Worldwide Inc.

  • EAG Inc.

  • Envigo

  • Eurofins Scientific

  • Intertek Team plc

  • IMR Examination Labs

  • Health care System Screening Services

  • North American Science Associates Inc.

  • NSF Worldwide

  • Rate Analytical Companies LLC.

  • SGS SA

  • Toxikon Inc.

  • Wuxi AppTec.

For extra information about this report check out https://www.researchandmarkets.com/r/5jsgc3-product?w=12

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s primary supply for intercontinental market place exploration reports and market place data. We provide you with the newest information on global and regional marketplaces, critical industries, the leading providers, new goods and the most up-to-date tendencies.

Make contact with: Make contact with: ResearchAndMarkets.com Laura Wooden,Senior Push Supervisor press@researchandmarkets.com For E.S.T Business Hours Simply call 1-917-300-0470 For U.S./ CAN Toll Cost-free Connect with 1-800-526-8630 For GMT Office Several hours Simply call +353-1-416-8900
Posted on

Medical Technology Company President Convicted in $77 Million COVID-19 and Allergy Testing Scheme | OPA

Medical Technology Company President Convicted in Million COVID-19 and Allergy Testing Scheme | OPA

A federal jury convicted the president of a Silicon Valley-based mostly clinical technological know-how company yesterday of collaborating in a plan to mislead traders, dedicate well being treatment fraud, and pay out illegal kickbacks in relationship with the submission of over $77 million in fake and fraudulent statements for COVID-19 and allergy tests.

Mark Schena, 59, of Los Altos, California, served as the president of Arrayit Corporation. According to court paperwork and evidence offered at demo, Schena engaged in a plan to defraud Arrayit’s traders by declaring that he experienced invented innovative technological innovation to exam for almost any illness using only a number of drops of blood. In conferences with buyers, Schena and his publicist claimed that Schena was the “father of microarray technology” and falsely stated that he was on the shortlist for the Nobel Prize. The evidence at trial showed that Schena also falsely represented to traders that Arrayit could be valued at $4.5 billion based on purported revenues of $80 million per year. 

In furtherance of the plan, the proof at trial showed that Schena, among other things, failed to launch Arrayit’s SEC-demanded financial disclosures and concealed that Arrayit was on the verge of bankruptcy. Schena lulled investors who ended up concerned that the organization was a “scam” by inviting them to private conferences and issuing fake press releases and tweets stating that Arrayit experienced entered into worthwhile partnerships with organizations, govt organizations, and community establishments, like a children’s hospital and a main California wellness treatment supplier. The tweets and push releases falsely claimed that these types of entities had agreed to use the Arrayit engineering, when in fact no this kind of agreements existed or have been of minimal worth. 

Schena also orchestrated an illegal kickback and overall health care fraud plan that involved submitting fraudulent promises to Medicare and personal insurance plan for unwanted allergy screening. Arrayit ran allergy screening exams on every affected person for 120 unique allergens (ranging from hornet stings to codfish) regardless of clinical necessity. In buy to obtain client blood specimens, Schena compensated kickbacks to entrepreneurs in violation of the Eradicating Kickbacks in Restoration Act and orchestrated a misleading marketing and advertising system that falsely claimed that the Arrayit take a look at was really accurate in diagnosing allergic reactions, when it was not, in point, a diagnostic exam. Arrayit billed extra for each affected person to Medicare for blood-dependent allergy tests than any other laboratory in the United States, the evidence at trial confirmed, and billed some professional insurers in excess of $10,000 for each examination.

In early 2020, Arrayit’s allergy screening business declined simply because the COVID-19 pandemic and stay-at-home orders lessened desire for allergy testing. Schena then falsely declared that Arrayit “had a check for COVID-19” based mostly on Arrayit’s blood testing technological innovation, ahead of establishing such a exam. Trying to find to capitalize on the nationwide lack of COVID-19 screening, Schena orchestrated a deceptive marketing and advertising scheme that falsely claimed that Dr. Anthony Fauci and other popular government officers experienced mandated testing for COVID-19 and allergy symptoms at the very same time and necessary that individuals receiving the Arrayit COVID-19 examination also be analyzed for allergy symptoms. Schena also falsely claimed that the Arrayit COVID-19 take a look at was much more accurate than a PCR check for diagnosing COVID-19 bacterial infections, while concealing from traders and clients taking the exam that the Meals and Drug Administration had informed him that the Arrayit take a look at was not precise ample to acquire an Crisis Use Authorization for use in the United States.

Schena was convicted of one depend of conspiracy to commit wellness care fraud and conspiracy to commit wire fraud, two counts of health care fraud, one rely of conspiracy to pay kickbacks, two counts of payment of kickbacks, and 3 counts of securities fraud. He is scheduled to be sentenced on Jan. 30, 2023 and faces a most penalty 20 a long time imprisonment for the conspiracy to commit health and fitness care fraud and conspiracy to commit wire fraud 10 yrs of imprisonment for each count of well being treatment fraud 5 yrs imprisonment for conspiracy to shell out kickbacks 10 yrs imprisonment for just about every depend of payment of kickbacks and 20 several years imprisonment for each and every count of securities fraud. U.S. District Judge Edward J. Davila will decide any sentence just after contemplating the U.S. Sentencing Rules and other statutory variables.

Assistant Lawyer Normal Kenneth A. Polite, Jr. of the Justice Department’s Criminal Division U.S. Lawyer Stephanie M. Hinds for the Northern District of California Specific Agent in Demand Craig D. Fair of the FBI’s San Francisco Field Business Performing Specific Agent in Cost Steven J. Ryan of the U.S. Office of Well being and Human Solutions Place of work of Inspector Typical (HHS-OIG) Inspector in Charge Delany De Leon-Colon of the U.S. Postal Inspection Services (USPIS) – Legal Investigations Team Particular Agent in Cost Kim R. Lampkins of the Veterans Affairs Place of work of Inspector Normal (VA-OIG) and Exclusive Agent in Demand Bryan D. Denny of the Defense Legal Investigative Assistance (DCIS) Western Field Business office produced the announcement.

HHS-OIG’s San Francisco Regional Workplace and Detroit Regional Office, USPIS, the FBI, VA-OIG and DCIS investigated the circumstance.

Performing Principal Assistant Chief Jacob Foster and Demo Lawyer Laura Connelly of the Justice Department’s Fraud Portion and Assistant U.S. Legal professional Christina Liu for the Northern District of California are prosecuting the situation.

The Fraud Segment makes use of the Target Notification Process (VNS) to deliver victims with situation info and updates associated to this case. Victims with concerns could speak to the Fraud Section’s Target Help Device by contacting the Sufferer Help cell phone line at 1-888-549-3945 or by emailing Victimassistance.fraud@usdoj.gov. To learn much more about victims’ rights, please visit: https://www.justice.gov/prison-vns/victim-legal rights-derechos-de-las-v-ctimas. If you imagine you are a target who has invested in Arrayit, or you have taken a COVID-19 test geared up or promoted by Arrayit, remember to take a look at https://www.justice.gov/prison-vns/scenario/Arrayit.